2025: Digital Asset Insights You Need to Know

Cryptocurrencies are taking off again, and those in-the-know are positioning themselves to ride this wave in 2025. The question is—will you be one of them? With explosive growth on the horizon, there’s never been a better time to understand the potential gains in crypto. Our guide, Navigating the Future: Cryptos to Watch in 2025, reveals the cryptos leading this surge and the strategies to maximize your profit potential.

PSTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Poseida Therapeutics Insider Trading History Chart

Poseida Therapeutics Share Price & Price History

^$2.73

▲ +0.02 (0.74%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

Buffett Dumps $982 Million in BofA Stock—What Does He Know?

From Genesis Gold Group | Ad

Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.

Get your FREE, no-obligation Wealth Protection Guide now

Poseida Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/8/2022	Eric Ostertag	Chairman	Buy	142,857	$3.50	$499,999.50	838,824
8/8/2022	Life Sciences Holdings L Malin	Major Shareholder	Buy	2,150,000	$3.50	$7,525,000.00	11,835,673
8/3/2022	Eric Ostertag	Chairman	Sell	160,696	$3.69	$592,968.24	695,967
3/16/2022	Kerry D. Ingalls	COO	Buy	3,000	$3.98	$11,940.00
12/6/2021	Life Sciences Holdings L Malin	Director	Buy	1,828	$6.90	$12,613.20
12/1/2021	Life Sciences Holdings L Malin	Director	Buy	18,365	$6.85	$125,800.25
11/29/2021	Life Sciences Holdings L Malin	Director	Buy	11,057	$6.89	$76,182.73
11/26/2021	Life Sciences Holdings L Malin	Director	Buy	27,251	$6.81	$185,579.31

Let’s be blunt

From DTI | Ad

Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

Check out the $100 Challenge now

SEC Filings (Institutional Ownership Changes) for Poseida Therapeutics (NASDAQ:PSTX)

46.87% of Poseida Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Poseida Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/20/2024	Virtu Financial LLC	13,035	$37K	0.0%	N/A	0.013%
11/19/2024	Barclays PLC	120,464	$0.35M	0.0%	+132.7%	0.124%
11/16/2024	Geode Capital Management LLC	1,617,137	$4.63M	0.0%	-0.3%	1.659%
11/15/2024	Barclays PLC	120,464	$0.35M	0.0%	+132.7%	0.124%
11/15/2024	XTX Topco Ltd	182,888	$0.52M	0.0%	+47.1%	0.188%
11/15/2024	Jane Street Group LLC	103,427	$0.30M	0.0%	-5.2%	0.106%
11/15/2024	Wellington Management Group LLP	308,363	$0.88M	0.0%	-20.4%	0.316%
11/15/2024	State Street Corp	1,710,565	$4.89M	0.0%	+2.3%	1.755%
11/15/2024	Jacobs Levy Equity Management Inc.	811,512	$2.32M	0.0%	-12.5%	0.833%
11/14/2024	Fred Alger Management LLC	128,970	$0.37M	0.0%	N/A	0.132%
11/13/2024	Advantage Alpha Capital Partners LP	99,566	$0.29M	0.1%	N/A	0.102%
11/13/2024	FMR LLC	14,570,078	$41.67M	0.0%	+0.2%	14.950%
11/12/2024	Charles Schwab Investment Management Inc.	567,063	$1.62M	0.0%	+3.9%	0.584%
11/9/2024	Intech Investment Management LLC	16,159	$46K	0.0%	N/A	0.017%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	359,197	$1.03M	0.0%	+62.8%	0.370%
11/6/2024	Cornercap Investment Counsel Inc.	43,177	$0.12M	0.0%	-45.5%	0.044%
11/2/2024	Privium Fund Management B.V.	77,500	$0.22M	0.1%	N/A	0.080%
10/3/2024	SG Americas Securities LLC	24,417	$70K	0.0%	N/A	0.025%
8/15/2024	Mackenzie Financial Corp	17,616	$51K	0.0%	N/A	0.018%
8/15/2024	The Manufacturers Life Insurance Company	28,520	$83K	0.0%	+14.2%	0.029%
8/15/2024	AQR Capital Management LLC	51,741	$0.15M	0.0%	+376.5%	0.053%
8/14/2024	Squarepoint Ops LLC	82,637	$0.24M	0.0%	N/A	0.085%
8/14/2024	Marshall Wace LLP	10,538	$31K	0.0%	N/A	0.011%
8/12/2024	XTX Topco Ltd	124,301	$0.36M	0.0%	+37.1%	0.128%
8/12/2024	Blair William & Co. IL	1,101,325	$3.22M	0.0%	+14.1%	1.136%
8/9/2024	Renaissance Technologies LLC	854,900	$2.50M	0.0%	+53.4%	0.882%
8/9/2024	Dimensional Fund Advisors LP	599,812	$1.75M	0.0%	+1.6%	0.619%
8/8/2024	American Century Companies Inc.	90,487	$0.26M	0.0%	+5.9%	0.093%
8/6/2024	Acadian Asset Management LLC	399,839	$1.17M	0.0%	+9.4%	0.412%
8/1/2024	Rhumbline Advisers	97,012	$0.28M	0.0%	+4.2%	0.100%
7/31/2024	Rothschild Investment LLC	12,000	$35K	0.0%	N/A	0.012%
7/29/2024	Principal Financial Group Inc.	12,006	$35K	0.0%	N/A	0.012%
7/26/2024	Bank of New York Mellon Corp	228,700	$0.67M	0.0%	+13.0%	0.236%
5/16/2024	Jacobs Levy Equity Management Inc.	830,127	$2.65M	0.0%	+89.4%	0.856%
5/16/2024	Bayesian Capital Management LP	10,200	$33K	0.0%	N/A	0.011%
5/15/2024	Public Employees Retirement System of Ohio	62,945	$0.20M	0.0%	+177.3%	0.065%
5/15/2024	Lazard Asset Management LLC	28,679	$91K	0.0%	+280.3%	0.030%
5/10/2024	Acadian Asset Management LLC	365,518	$1.17M	0.0%	-27.1%	0.377%
5/10/2024	Vanguard Group Inc.	3,373,065	$10.76M	0.0%	+16.3%	3.480%
5/9/2024	Blair William & Co. IL	965,052	$3.08M	0.0%	+41.3%	0.996%
5/8/2024	Russell Investments Group Ltd.	34,503	$0.11M	0.0%	N/A	0.036%
5/7/2024	SG Americas Securities LLC	28,511	$91K	0.0%	-22.9%	0.029%
2/16/2024	Public Employees Retirement System of Ohio	22,700	$76K	0.0%	N/A	0.024%
2/15/2024	Cantor Fitzgerald L. P.	50,205	$0.17M	0.0%	N/A	0.053%
2/13/2024	Tower Research Capital LLC TRC	10,679	$36K	0.0%	+110.5%	0.011%
2/9/2024	Dynamic Technology Lab Private Ltd	10,459	$36K	0.0%	N/A	0.011%
2/1/2024	New York State Common Retirement Fund	22,763	$76K	0.0%	-44.1%	0.024%
2/1/2024	MCF Advisors LLC	247,024	$0.83M	0.1%	+476.4%	0.258%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	114,011	$0.38M	0.0%	-56.1%	0.119%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	342,857	$0.82M	0.0%	+186.7%	0.394%
11/13/2023	Acadian Asset Management LLC	851,839	$2.03M	0.0%	-23.4%	0.980%
11/13/2023	Silverarc Capital Management LLC	3,567,985	$8.49M	2.6%	+21.1%	4.105%
11/13/2023	FMR LLC	13,037,429	$31.03M	0.0%	+0.2%	14.999%
11/9/2023	Blair William & Co. IL	740,650	$1.76M	0.0%	+30.2%	0.852%
11/7/2023	Barclays PLC	45,542	$0.11M	0.0%	+40.7%	0.052%
11/6/2023	Keystone Financial Group	15,000	$36K	0.0%	N/A	0.017%
10/27/2023	Allspring Global Investments Holdings LLC	12,247	$29K	0.0%	N/A	0.014%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	259,929	$0.62M	0.0%	+10.2%	0.299%
10/26/2023	Strs Ohio	20,100	$47K	0.0%	N/A	0.023%
9/21/2023	Barclays PLC	32,368	$57K	0.0%	-68.4%	0.037%
9/8/2023	Tucker Asset Management LLC	19,096	$34K	0.0%	+156.2%	0.022%
8/15/2023	Silverarc Capital Management LLC	2,945,948	$5.19M	1.6%	+9.5%	3.389%
8/14/2023	Graham Capital Management L.P.	19,038	$34K	0.0%	N/A	0.022%
8/11/2023	Penserra Capital Management LLC	49,027	$86K	0.0%	+142.6%	0.056%
8/7/2023	Acadian Asset Management LLC	1,111,372	$1.95M	0.0%	+9.9%	1.281%
8/4/2023	American International Group Inc.	32,712	$58K	0.0%	N/A	0.038%
8/3/2023	Mackenzie Financial Corp	18,832	$33K	0.0%	N/A	0.022%
7/25/2023	DekaBank Deutsche Girozentrale	100,000	$0.16M	0.0%	+25.0%	0.115%
7/10/2023	SG Americas Securities LLC	31,016	$55K	0.0%	+29.4%	0.036%
6/13/2023	Callan Capital LLC	68,007	$0.21M	0.0%	+9.1%	0.078%
5/15/2023	Globeflex Capital L P	91,246	$0.28M	0.0%	N/A	0.105%
5/11/2023	Acadian Asset Management LLC	1,011,383	$3.12M	0.0%	+406.8%	1.166%
5/11/2023	Cornercap Investment Counsel Inc.	41,008	$0.13M	0.0%	-38.0%	0.047%
5/11/2023	Knott David M Jr	140,921	$0.43M	0.2%	-16.5%	0.162%
5/9/2023	Y Intercept Hong Kong Ltd	43,321	$0.13M	0.0%	N/A	0.050%
5/9/2023	Callan Capital LLC	68,007	$0.21M	0.0%	+9.1%	0.078%
5/4/2023	Barclays PLC	102,545	$0.32M	0.0%	+76.5%	0.118%
5/3/2023	Jump Financial LLC	122,091	$0.38M	0.0%	+88.1%	0.141%
5/1/2023	Virtu Financial LLC	22,806	$70K	0.0%	+28.2%	0.026%
4/28/2023	SG Americas Securities LLC	23,960	$74K	0.0%	N/A	0.028%
4/27/2023	Arizona State Retirement System	13,697	$42K	0.0%	N/A	0.016%
4/24/2023	Penserra Capital Management LLC	20,210	$62K	0.0%	-29.3%	0.023%
4/12/2023	FNY Investment Advisers LLC	10,000	$30K	0.0%	N/A	0.012%
2/14/2023	683 Capital Management LLC	36,966	$0.20M	0.0%	N/A	0.043%
2/13/2023	Callan Capital LLC	62,347	$0.33M	0.0%	N/A	0.073%
2/13/2023	GSA Capital Partners LLP	95,469	$0.51M	0.1%	N/A	0.111%
2/13/2023	Knott David M Jr	168,839	$0.90M	0.3%	+11.6%	0.196%
2/10/2023	HRT Financial LP	200,351	$1.06M	0.0%	N/A	0.233%
2/10/2023	Blair William & Co. IL	19,143	$0.10M	0.0%	+8.5%	0.022%
2/9/2023	Citigroup Inc.	163,675	$0.87M	0.0%	+5,651.1%	0.190%
2/1/2023	Bank of Montreal Can	399,472	$1.62M	0.0%	-22.9%	0.465%
1/31/2023	MCF Advisors LLC	42,854	$0.23M	0.0%	-17.4%	0.050%
11/15/2022	Perceptive Advisors LLC	750,000	$2.65M	0.1%	N/A	0.873%
11/15/2022	EcoR1 Capital LLC	2,650,000	$9.36M	0.3%	N/A	3.083%
11/14/2022	Pentwater Capital Management LP	5,975,000	$21.09M	0.2%	+20.3%	7.222%
11/14/2022	Cormorant Asset Management LP	1,850,000	$6.53M	0.5%	N/A	2.236%
11/14/2022	Ergoteles LLC	93,842	$0.33M	0.0%	-31.2%	0.113%
11/14/2022	Penserra Capital Management LLC	71,587	$0.25M	0.0%	N/A	0.087%
11/14/2022	Crown Advisors Management Inc.	150,000	$0.53M	0.5%	N/A	0.181%
11/14/2022	Forefront Analytics LLC	15,650	$59K	0.0%	-33.0%	0.019%

Data available starting January 2016

Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company's development candidates for Heme Malignancies includes P-BCMA-ALLO1, which is in Phase I trial to treat patients with relapsed/refractory multiple myeloma; P-CD19CD20-ALLO1, which is in Phase I trial for treating B cell malignancies and other autoimmune diseases; P-BCMACD19-ALLO1, an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for treating multiple myeloma; and P-CD70-ALLO1 under preclinical development to treat hematological indications. It is also involved in the development of P-MUC1C-ALLO1 that is in Phase I trial for treating a range of solid tumors, including breast, colorectal, lung, ovarian, pancreatic, and renal cancers; P-PSMA-ALLO1, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in preclinical development for the treatment of patients with metastatic castrate resistant prostate cancer (mCRPC); and P-PSMA-101, an allogeneic CAR-T product candidate under Phase 1 clinical trial for treating mCRPC. In addition, the company engages in the development of P-FVIII-101, a clinical stage liver-directed gene therapy for the in vivo treatment of hemophilia A; P-OTC-101, a clinical stage liver-directed gene therapy for the in vivo treatment of ornithine transcarbamylase deficiency; and P-PAH-101, a clinical stage liver-directed gene therapy for the in vivo treatment of phenylketonuria. It has a research collaboration and license agreement with F. Hoffmann-La Roche Ltd, and Hoffmann-La Roche Inc. The company was incorporated in 2014 and is headquartered in San Diego, California.

Today's Range

Now: $2.73

$2.69

$2.87

50 Day Range

MA: $2.79

$2.37

$3.71

52 Week Range

Now: $2.73

$1.87

$4.27

Volume

364,903 shs

Average Volume

560,478 shs

Market Capitalization

$266.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.54

Who are the major institutional investors of Poseida Therapeutics?: Poseida Therapeutics' top institutional shareholders include:
FMR LLC — 14.95%
State Street Corp — 1.76%
Geode Capital Management LLC — 1.66%
Jacobs Levy Equity Management Inc. — 0.83%
Charles Schwab Investment Management Inc. — 0.58%
Connor Clark & Lunn Investment Management Ltd. — 0.37%
Learn More about top institutional investors of Poseida Therapeutics stock.
Which major investors are selling Poseida Therapeutics stock?: In the last quarter, PSTX stock was sold by these institutional investors:
Jacobs Levy Equity Management Inc.
Wellington Management Group LLP
Cornercap Investment Counsel Inc.
Jane Street Group LLC
Geode Capital Management LLC
Which major investors are buying Poseida Therapeutics stock?: Within the previous quarter, PSTX stock was bought by institutional investors including:
Connor Clark & Lunn Investment Management Ltd.
Fred Alger Management LLC
Advantage Alpha Capital Partners LP
Privium Fund Management B.V.
Barclays PLC
Barclays PLC
XTX Topco Ltd
State Street Corp